Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Masimo Gets FDA Nod for MightySat Medical OTC Fingertip Pulse Oximeter - Medical Product Outsourcing
OEM News

Masimo Gets FDA Nod for MightySat Medical OTC Fingertip Pulse Oximeter

MightySat Medical is meant for spot-checking functional oxygen saturation of arterial hemoglobin and pulse rate.

Masimo has received U.S. Food and Drug Administration (FDA) clearance for MightySat Medical, a medical fingertip pulse oximeter that’s available over-the-counter (OTC) direct to consumers, without a prescription. It’s the first such device of its kind, according to the company.
 
MightySat Medical is meant for spot-checking of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate. It offers accurate, reliable measurements on patients of all skin colors and patients with low perfusion.
 
It provides a direct-to-consumer option for medical device with hospital-grade pulse oximetry technology, Masimo SET. The company said that over 100 independent and objective studies has demonstrated that SET outperforms other pulse oximetry technologies.
 
“Until now, consumers and even healthcare providers had no way of knowing what pulse oximeter they could trust to use at home,” said Masimo founder and CEO Joe Kiani. “On the internet and even in drug stores, they are inundated with a myriad of products that are unreliable, with misleading advertisements about their abilities to provide accurate measurements of oxygen saturation and pulse rate.”
 
“This clearance of MightySat Medical for consumers eliminates the confusion, placing an FDA-cleared, accurate, reliable, and revolutionary SET pulse oximeter, with technology that hospitals have been using for more than 25 years, directly into their hands,” Kiani continued. “Healthcare providers can also now be confident when referring their patients to get MightySat Medical knowing that it has actually been cleared by the FDA as an OTC medical pulse oximeter.”
 
In December 2023, Masimo earned FDA clearance of its Stork baby monitoring system for prescription, home use for healthy and sick babies 0-18 months old.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters